As of 2025-10-29, the Relative Valuation of Nova Mentis Life Science Corp (NOVA.CN) is (1.22) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 CAD, the upside of Nova Mentis Life Science Corp based on Relative Valuation is -3145.5%.
The range of the Relative Valuation is (1.57) - (0.77) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 34.6x - 40.1x | 37.4x |
| Forward P/E multiples | 15.8x - 17.1x | 16.4x |
| Fair Price | (1.57) - (0.77) | (1.22) |
| Upside | -4015.0% - -2031.5% | -3145.5% |
| Date | P/E |